Clinical Trials Logo

Tachyarrhythmia clinical trials

View clinical trials related to Tachyarrhythmia.

Filter by:

NCT ID: NCT03451227 Terminated - Tachyarrhythmia Clinical Trials

Dexmedetomidine and Fentanyl Versus Midazolam and Remifentanil for Sedation in Patients Undergoing Ablation Procedures

Start date: December 1, 2017
Phase: N/A
Study type: Interventional

To evaluate the safety and efficacy of dexmedetomidine and compare this to a current technique commonly used at TGH for sedation in patients undergoing ablation procedures for atrial fibrillation (AF) and atrial flutter. The investigators hypothesise that dexmedetomidine will be at least equivalent to, or more so, in terms of effectiveness and safety, when compared to midazolam and remifentanil for sedation during ablation procedures.

NCT ID: NCT03408951 Completed - Clinical trials for Arrhythmias, Cardiac

Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment

Start date: March 2, 2017
Phase:
Study type: Observational

Recorded cutaneous ECG containing arrhythmia events are separately analysed by an expert Electrophysiologist and the ISSD detection algorithm, to allow assessment of the correct detection of tachyarrhythmia events and discrimination of supra-ventricular arrhythmia of the algorithm,m compared to the expert.

NCT ID: NCT02933619 Completed - Tachyarrhythmia Clinical Trials

ProMRI ICD/CRT-D Post Approval Study

Start date: August 2016
Phase:
Study type: Observational

Following product approval, confirmation of appropriate VF episode detection after MRI exposure of the ProMRI ICD/CRT-D systems and to evaluate left ventricular pacing threshold changes post-MRI.

NCT ID: NCT02849769 Completed - Tachyarrhythmia Clinical Trials

Magnetic Resonance (MR) Conditional Tachyarrhythmia Therapy Products Post-approval Study

Start date: September 2015
Phase:
Study type: Observational

Following product approval, further confirmation of the MR Conditional Tachyarrhythmia Therapy Systems sensing and detection performance post MRI exposure will be obtained by actively monitoring de-identified device data obtained through the Medtronic CareLink® Network.

NCT ID: NCT02774616 Completed - Heart Failure Clinical Trials

BIO|MASTER.Ilivia Family / Plexa

Start date: June 2016
Phase: N/A
Study type: Interventional

Post-Market Clinical Follow-up of the new Ilivia ICD Family and the new Plexa right ventricular lead to fulfill requirements by the notified body and to support regulatory approval outside of the CE region

NCT ID: NCT02565238 Completed - Atrial Fibrillation Clinical Trials

BIO.MASTER.BioMonitor 2 Study

Start date: September 2015
Phase: N/A
Study type: Observational [Patient Registry]

The objective of the study is to confirm safety and efficacy of the BioMonitor 2. The data is collected to support the regulatory approval of this product in countries outside the CE region.

NCT ID: NCT02181686 Completed - Heart Failure Clinical Trials

Iperia/Sentus QP Study

Start date: July 2014
Phase: N/A
Study type: Observational

The objective of this study is to confirm the safety and efficacy of the new Sentus OTW QP LV lead and Iperia ICD family. The study focuses on the safety and efficacy of the QP device system.

NCT ID: NCT01526629 Active, not recruiting - Tachyarrhythmia Clinical Trials

Full Automaticity and Remote Follow-up

Start date: May 2011
Phase: N/A
Study type: Observational

With the expansion of Sudden Cardiac Death (SCD) primary prevention indications, the number of Implantable Cardioverter Defibrillators (ICD) implants has increased significantly in the recent years. This has resulted in an increase of the number of follow-up (FU) to be performed and a growing workload for centers. Remote FU system such as the Medtronic Carelink system allows to check remotely the proper functioning of self evaluating devices and give informations of some clinical events. The objective of this study is to define which patients with a remote follow-up need additional onsite visit and to assess to which extent remote FU can be an alternative to onsite visit.

NCT ID: NCT00324662 Completed - Tachyarrhythmia Clinical Trials

Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA)

Start date: August 2003
Phase: Phase 4
Study type: Interventional

A unique single-lead dual-chamber implantable cardioverter-defibrillator (ICD) system (produced by Biotronik, Germany) features a conventional electrode in the ventricle (anchored in the ventricular apex) and a floating electrode (ring on the lead body) in the atrium, capable of sensing atrial electrical signals. The purpose of this study is to determine whether this system detects a supraventricular tachyarrhythmia (e.g. atrial fibrillation, atrial tachycardia) in the equivalent manner as conventional dual-lead dual-chamber ICDs using two separate electrodes anchored in the ventricle and in the atrium, respectively.

NCT ID: NCT00231426 Completed - Tachyarrhythmia Clinical Trials

ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations

Start date: June 2003
Phase: Phase 4
Study type: Interventional

The ASSURE Study will evaluate shock conversion performance when programming the first shock of an implantable cardioverter-defibrillation (ICD) is based on an implant test consisting of either 1) a single induction of ventricular fibrillation (VF) and subsequent demonstration conversion success at 14 J or 2) an upper limit of vulnerability (ULV) test at 14 J.